Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable lung condition marked by persistent airflow limitation and respiratory symptoms — chronic breathlessness, cough, and sputum — that arise from abnormalities of the airways (bronchitis) and alveoli (emphysema), usually after long exposure to noxious particles or gases. For respiratory nursing it is a central long-term condition defined by stable-phase management punctuated by acute exacerbations.

Definition

Chronic obstructive pulmonary disease is a heterogeneous lung condition characterised by chronic respiratory symptoms (dyspnoea, cough, sputum production) due to abnormalities of the airways and/or alveoli that cause persistent, often progressive airflow obstruction, as defined in the GOLD report (Agustí et al., 2023).

Scope

This entry covers COPD as a clinical entity within respiratory nursing: its definition by persistent airflow limitation, the mechanisms underlying it, the burden of exacerbations, and the guideline framework (GOLD) that organises assessment and care. It is written for reference and education and does not provide dosing or individualised treatment instructions.

Core questions

• What distinguishes persistent airflow limitation in COPD from reversible obstruction?
• How do airway and alveolar abnormalities give rise to COPD's symptoms?
• Why do exacerbations matter for disease trajectory and nursing assessment?
• How does the GOLD framework structure assessment and monitoring?

Key concepts

• Persistent airflow limitation
• Chronic bronchitis and emphysema
• Exacerbations
• Dyspnoea and symptom burden
• Tobacco smoke and noxious exposure
• Spirometric confirmation
• GOLD assessment framework
• Pulmonary rehabilitation

Mechanisms

COPD develops when chronic exposure to inhaled irritants — most commonly tobacco smoke, but also biomass and occupational exposures — provokes inflammation and structural change in the small airways and alveoli. Airway inflammation, mucus hypersecretion, and remodelling narrow the conducting airways, while emphysematous destruction of alveolar walls reduces elastic recoil and the surface area for gas exchange; together these produce the persistent, incompletely reversible airflow limitation that defines the disease, alongside abnormal lung development and accelerated lung-function decline in susceptible individuals (Agustí & Hogg, 2019).

Clinical relevance

COPD is a frequent reason adults present for medical-surgical and respiratory nursing care, both for stable-disease support and for acute exacerbations that may require hospital admission and ventilatory support. The entry describes the condition and its guideline context to orient assessment and patient education; it is not a basis for prescribing or titrating treatment.

Epidemiology

COPD is one of the leading chronic respiratory diseases and causes of death worldwide, with prevalence rising with age and cumulative exposure to tobacco smoke and other inhaled irritants; the GOLD report tracks its global burden, and longitudinal data show that frequent exacerbations are associated with faster decline in lung function (Donaldson et al., 2002).

Evidence & guidelines

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) report is the principal international framework for defining, assessing, and categorising COPD (Agustí et al., 2023). For acute hypercapnic exacerbations, ERS/ATS clinical practice guidelines support noninvasive ventilation as a recommended supportive modality (Rochwerg et al., 2017). These documents describe evidence and recommendations at a population and care-organisation level rather than individualised orders.

Seminal works

• agusti-2023-gold
• agusti-2019-pathogenesis
• donaldson-2002-exacerbations

Frequently asked questions

Is the airflow limitation in COPD reversible?

No; COPD is defined by persistent, often progressive airflow limitation that is not fully reversible, which distinguishes it from the variable, more reversible obstruction characteristic of asthma.

Why are exacerbations important in COPD?

Exacerbations are acute worsenings of symptoms that prompt care escalation, and frequent exacerbations have been associated with faster decline in lung function over time.